Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Metab Cardiovasc Dis ; 25(4): 403-10, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25698153

ABSTRACT

BACKGROUND AND AIMS: South Asians have a higher risk of developing cardiovascular disease than white Caucasians. The underlying cause is unknown, but might be related to higher cardiac susceptibility to metabolic disorders. Short-term caloric restriction (CR) can be used as a metabolic stress test to study cardiac flexibility. We assessed whether metabolic and functional cardiovascular flexibility to CR differs between South Asians and white Caucasians. METHODS AND RESULTS: Cardiovascular function and myocardial triglycerides were assessed using a 1.5T-MRI/S-scanner in 12 middle-aged overweight male South Asians and 12 matched white Caucasians before and after an 8-day very low calorie diet (VLCD). At baseline South Asians were more insulin resistant than Caucasians. Cardiac dimensions were smaller, despite correction for body surface area, and pulse wave velocity (PWV) in the distal aorta was higher in South Asians. Systolic and diastolic function, myocardial triglycerides and pericardial fat did not differ significantly between groups. After the VLCD body weight reduced on average by 4.0 ± 0.2 kg. Myocardial triglycerides increased in both ethnicities by 69 ± 18%, and diastolic function decreased although this was not significant in South Asians. However, pericardial fat and PWV in the proximal and total aorta were reduced in Caucasians only. CONCLUSION: Myocardial triglyceride stores in middle-aged overweight and insulin resistant South Asians are as flexible and amenable to therapeutic intervention by CR as age-, sex- and BMI-matched but less insulin resistant white Caucasians. However, paracardial fat volume and PWV showed a differential effect in response to an 8-day VLCD in favor of Caucasians. CLINICAL TRIAL REGISTRATION: NTR 2473 (URL: http://www.trialregister.nl/trialreg/admin/rctsearch.asp?Term=2473).


Subject(s)
Asian People , Caloric Restriction , Cardiovascular System/metabolism , Overweight/blood , White People , Adipose Tissue/metabolism , Adult , Blood Glucose/metabolism , Body Mass Index , Body Surface Area , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Glycated Hemoglobin/metabolism , Humans , Insulin/blood , Insulin Resistance , Male , Middle Aged , Myocardium/metabolism , Prospective Studies , Pulse Wave Analysis , Triglycerides/blood
3.
Br J Cancer ; 109(4): 891-6, 2013 Aug 20.
Article in English | MEDLINE | ID: mdl-23922115

ABSTRACT

BACKGROUND: After treatment with cisplatin-based chemotherapy for testicular cancer (TC), patients have higher prevalence of cardiovascular complications after long-term follow up. Little is known about acute cardiovascular effects of cisplatin-based chemotherapy. The aim of this study was to explore acute effects of chemotherapy on cardiac function in patients treated for TC. METHODS: Fourteen TC patients (age 34.6 ± 12.3 years) were studied before and 3 months after start with cisplatin-based chemotherapy. Cardiac function was assessed with magnetic resonance imaging. Fasting glucose and insulin levels were measured and insulin sensitivity, reflected by the quantitative insulin sensitivity index (Quicki index), was calculated. RESULTS: Left ventricular (LV) end-diastolic volume and LV stroke volume (SV) significantly decreased from 192 ± 27 to 175 ± 26 ml (P<0.05) and 109 ± 18 to 95 ± 16 ml (P<0.05), respectively. The ratio of early and atrial filling velocities across the mitral valve, a parameter of diastolic heart function, decreased after chemotherapy from 1.87 ± 0.43 to 1.64 ± 0.45 (P<0.01). Metabolic parameters were unfavourably changed, reflected by a decreased Quicki index, which reduced from 0.39 ± 0.05 to 0.36 ± 0.05 (P<0.05). CONCLUSION: Chemotherapy for TC induces acute alterations in diastolic heart function, paralleled by unfavourable metabolic changes. Therefore, early after chemotherapy, metabolic treatment may be indicated to possibly reduce long-term cardiovascular complications.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Heart/drug effects , Seminoma/drug therapy , Testicular Neoplasms/drug therapy , Ventricular Dysfunction, Left/chemically induced , Adult , Bleomycin/administration & dosage , Bleomycin/adverse effects , Cardiac-Gated Imaging Techniques , Cisplatin/administration & dosage , Cisplatin/adverse effects , Diastole/drug effects , Etoposide/administration & dosage , Etoposide/adverse effects , Humans , Insulin Resistance , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Male , Middle Aged , Myocardium/metabolism , Triglycerides/metabolism , Ventricular Function, Left/drug effects , Ventricular Function, Right/drug effects , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...